SCHEMBL22497280

SCHEMBL22497280

NS(=O)(=O)c1ccn(CC2CCOC2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ CASP7 P55210 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ PIK3CA P42336 3/20 0.35
▸ JAK2 O60674 1/20 0.35
▸ JAK1 P23458 1/20 0.35
▸ TYK2 P29597 1/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ NAMPT P43490 1/20 0.34
▸ CYP11B2 P19099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30366107 0.84 CA1 (0.44) ALDH1A1MAPTCA12CA1CA2
SCHEMBL29284959 0.81 CA2 (0.39) MAPTNPSR1CA12CA1CA2
SCHEMBL22524905 0.80 JAK2 (0.34) KDM4EALDH1A1GLAPOLBGAA
SCHEMBL29284933 0.79 TSHR (0.33) KDM4EALDH1A1POLBHPGDALOX15
SCHEMBL29284936 0.79 TSHR (0.33) KDM4EALDH1A1POLBHPGDALOX15
SCHEMBL20757429 0.76 CA1 (0.32) CA12CA1CA2CA9
SCHEMBL22497240 0.76 KDM4E (0.42) KDM4EALDH1A1POLBHPGDALOX15
SCHEMBL22497231 0.73 SOST (0.34) PIK3CAJAK2JAK1TYK2CA12
SCHEMBL22252587 0.72 IRAK4 (0.38) PIK3CANAMPTCYP11B2IRAK4SCD
SCHEMBL22252592 0.72 IRAK4 (0.38) PIK3CANAMPTCYP11B2IRAK4SCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12012392-B2 Sulfonamide carboxamide compounds INFLAZOME LIMITED (IE) 2024-06-18 — — US disclosed
US-20200317637-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS INFLAZOME LIMITED (IE) 2020-10-08 — — US disclosed
US-20200317637-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS INFLAZOME LIMITED (IE) 2020-10-08 — — US disclosed
CN-111315733-A Novel sulfonamide carboxamide compounds 英夫拉索姆有限公司 2020-06-19 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200317637-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS NLRP3, NOD1, PYCARD KDM4E 1872/4885ALDH1A1 1407/4885GLA 2360/4885
US-12012392-B2 Sulfonamide carboxamide compounds NLRP3, PYCARD, NOD1 KDM4E 1851/4885ALDH1A1 1293/4885GLA 2293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback